Biogen
In Brief This Week: Eisai, Biogen, Vertex, SpectronRx, Artbio, NorthStar Medical Radioisotopes
News items for the week of Jan.
Eisai, Biogen's Anti-Amyloid Alzheimer's Drug Leqembi Gains Full FDA Approval
On the heels of the announcement, CMS confirmed Medicare would cover the pricey drug for patients whose physicians agree to data collection requirements.